Acelyrin, Inc.
SLRN · NASDAQ
3/31/2025 | 12/31/2024 | 9/30/2024 | 6/30/2024 | |
|---|---|---|---|---|
| Market Cap | $249 | $312 | $492 | $420 |
| - Cash | $58 | $74 | $216 | $128 |
| + Debt | $6 | $6 | $7 | $1 |
| Enterprise Value | $196 | $244 | $282 | $293 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -100% | – | – | – |
| Gross Profit | $0 | $0 | -$0 | -$0 |
| % Margin | – | 50% | – | – |
| EBITDA | -$60 | -$28 | -$44 | -$93 |
| % Margin | – | -8,287.4% | – | – |
| Net Income | -$55 | -$79 | -$49 | -$86 |
| % Margin | – | -23,109.1% | – | – |
| EPS Diluted | -0.55 | -0.8 | -0.49 | -0.86 |
| % Growth | 31.3% | -63.3% | 43% | – |
| Operating Cash Flow | -$39 | -$122 | -$79 | -$46 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$1 |
| Free Cash Flow | -$39 | -$122 | -$79 | -$47 |